Latest Breaking News On - Bronchopulmonary dysplasia - Page 2 : comparemela.com

Belgium-based EXO Biologics raises €16M to harness the therapeutic potential of exosomes

Liège-based EXO Biologics, a clinical-stage biotech company, announced that it has secured a total of up to €16M in Series A funding. 

Later Hernia Repair in Preterm Infants Reduces Risks

A new study suggests that delaying inguinal hernia repair in preterm infants until after NICU discharge results in better outcomes compared with performing repair procedures before discharge.

Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialize OHB-607, a potentially transformative neonatal therapy

Study identifies key factor in lung and eye damage in preemies

Advancements in the care of premature babies are leading to improved survival rates. However, the incidence of neonatal diseases with life-long consequences such as bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) is increasing.

Alveolus Bio Enters Into Strategic Collaboration with BiomEdit

/PRNewswire/ Alveolus Bio today announced a strategic scientific collaboration with BiomEdit, an emerging animal health biotechnology company leveraging.